1. Home
  2. FFIV vs WAT Comparison

FFIV vs WAT Comparison

Compare FFIV & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FFIV
  • WAT
  • Stock Information
  • Founded
  • FFIV 1996
  • WAT 1958
  • Country
  • FFIV United States
  • WAT United States
  • Employees
  • FFIV N/A
  • WAT N/A
  • Industry
  • FFIV Computer Communications Equipment
  • WAT Biotechnology: Laboratory Analytical Instruments
  • Sector
  • FFIV Telecommunications
  • WAT Industrials
  • Exchange
  • FFIV Nasdaq
  • WAT Nasdaq
  • Market Cap
  • FFIV 16.9B
  • WAT 17.8B
  • IPO Year
  • FFIV 1999
  • WAT 1995
  • Fundamental
  • Price
  • FFIV $298.99
  • WAT $299.12
  • Analyst Decision
  • FFIV Buy
  • WAT Hold
  • Analyst Count
  • FFIV 12
  • WAT 15
  • Target Price
  • FFIV $292.55
  • WAT $377.80
  • AVG Volume (30 Days)
  • FFIV 407.3K
  • WAT 1.0M
  • Earning Date
  • FFIV 07-30-2025
  • WAT 08-04-2025
  • Dividend Yield
  • FFIV N/A
  • WAT N/A
  • EPS Growth
  • FFIV 26.37
  • WAT 8.23
  • EPS
  • FFIV 10.53
  • WAT 11.02
  • Revenue
  • FFIV $2,939,781,000.00
  • WAT $2,983,253,000.00
  • Revenue This Year
  • FFIV $9.69
  • WAT $6.27
  • Revenue Next Year
  • FFIV $4.21
  • WAT $6.49
  • P/E Ratio
  • FFIV $28.41
  • WAT $27.40
  • Revenue Growth
  • FFIV 5.61
  • WAT 2.57
  • 52 Week Low
  • FFIV $184.81
  • WAT $279.62
  • 52 Week High
  • FFIV $313.00
  • WAT $423.56
  • Technical
  • Relative Strength Index (RSI)
  • FFIV 53.39
  • WAT 38.19
  • Support Level
  • FFIV $296.66
  • WAT $279.62
  • Resistance Level
  • FFIV $305.98
  • WAT $305.87
  • Average True Range (ATR)
  • FFIV 5.54
  • WAT 10.72
  • MACD
  • FFIV -0.29
  • WAT 0.46
  • Stochastic Oscillator
  • FFIV 56.09
  • WAT 25.13

About FFIV F5 Inc.

F5 is a market leader in the application delivery controller market. The company sells products for security, application performance, and automation. Its three customer verticals are enterprises, service providers, and government entities. Revenue is evenly split between its services business and products business with revenue trending toward products due to software adoption. The Seattle-based firm was incorporated in 1996, and went public in 1999.

About WAT Waters Corporation

Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools.

Share on Social Networks: